BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SGS Life Science Services (SGSN) Expands Services, Adds Formulation Development in Lincolnshire, Illinois Laboratory


5/8/2012 11:47:17 AM

May 08, 2012 -- SGS, the world's leading inspection, verification, testing and certification company, today announces the availability of pre-formulation and formulation development services for large and small molecules at its Life Science Services laboratory in Lincolnshire, IL.

This service portfolio expansion encompasses liquid and lyophilized development services, as well as technology transfer to cGMP manufacturing. Some of the pre-formulation and formulation capabilities include: characterizing physico-chemical properties; improving solubility; developing stability assays; target product profiling; screening buffers, pH, surfactants and stabilizers; container-closure and pre-filled syringe compatibility and selection, and ANDA product development.

This expansion of services strategically positions SGS to “rapidly and cost-effectively move a customer’s molecules from development to clinic and maintain our established level of quality control,” according to Richard Bunnell, PhD, General Manger of the Lincolnshire site. “Our services are supported by strong in- house expertise in analytical and microbiology method development and ICH real-time and accelerated stability studies.”

SGS has recruited two formulation experts to lead the division. Dr. Leu-Fen H. Lin will manage large molecule formulation development, and brings more than 20 years of industrial experience in liquid/solid protein formulation and protein chemistry. Her colleague, Sunil Potdar, is team manager heading small molecule formulation development, drawing upon nine years experience in formulation development in sterile injectables and lyophilized products as well as sterile ophthalmic solutions and technology transfer.

With 19 laboratories offering contract analytical and bioanalytical services, SGS leverages its strong global network to deliver harmonized solutions to large pharmaceutical and biotechnology firms. In addition to testing services for the bio/pharmaceutical market, SGS also provides clinical trial management (Phase I to IV) and services encompassing clinical pharmacology studies, data management, pharmacovigilance and regulatory consultancy.

ABOUT SGS

SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognised as the global benchmark for quality and integrity. With more than 70,000 employees, SGS operates a network of over 1,350 offices and laboratories around the world.

FOR FURTHER INFORMATION, PLEASE CONTACT:

Ferdinand Dabu

Global Marketing Director

Life Science Services

SGS, 75 Passaic Avenue, Fairfield, NJ 07004, USA

Tel: +1-973-276-8463

E-mail: ferdinand.dabu@sgs.com

Website: www.sgs.com/pharmaqc



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES